Merck, 1078381000, Antimony(III) chloride

Application

Syntheses and characterization of novel antimony (III) and bismuth (III) derivatives containing β-enamino ester along with antimicrobial evaluation, DFT calculation, and cytotoxic study.: This study involved the synthesis and characterization of novel antimony(III) chloride derivatives. The research highlighted its applications in antimicrobial evaluation, density functional theory (DFT) calculations, and cytotoxic studies, demonstrating the compound′s potential in developing new antimicrobial agents (Sangwan et al., 2024).

Analysis Note
Assay (bromometric): ≥ 99.0 %
Matter insoluble in chloroform: ≤ 0.02 %
Substances insoluble in hydrochloric acid: ≤ 0.005 %
Sulfate (SO₄): ≤ 0.005 %
As (Arsenic): ≤ 0.005 %
Ca (Calcium): ≤ 0.005 %
Cu (Copper): ≤ 0.0005 %
Fe (Iron): ≤ 0.002 %
K (Potassium): ≤ 0.01 %
Na (Sodium): ≤ 0.005 %
Pb (Lead): ≤ 0.003 %
Other Notes
Replaces: AX1675
Legal Information
EMSURE is a registered trademark of Merck KGaA, Darmstadt, Germany